Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
5.04
+0.13 (2.65%)
Jul 3, 2026, 3:04 PM CST
Market Cap3.81B -19.2%
Revenue (ttm)2.99B +20.9%
Net Income38.74M -63.5%
EPS0.05 -63.9%
Shares Out 755.68M
PE Ratio101.47
Forward PE16.80
Dividend0.10 (1.98%)
Ex-Dividend DateJun 1, 2026
Volume11,551,100
Open4.79
Previous Close4.91
Day's Range4.79 - 5.09
52-Week Range4.58 - 8.06
Beta0.38
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,713
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Financial Statements